Skip to main content
CANN GROUP LIMITED logo

CANN GROUP LIMITED — Investor Relations & Filings

Ticker · CAN ISIN · AU000000CAN2 LEI · 529900XX42XELLXVQE42 ASX Manufacturing
Open in API
Filings indexed 729 across all filing types
Latest filing 2020-08-10 Capital/Financing Update
Country AU Australia
Listing ASX CAN

About CANN GROUP LIMITED

https://www.canngrouplimited.com/

Cann Group Limited specializes in the cultivation, manufacture, and supply of medicinal cannabis products. The company focuses on providing pharmaceutical-grade cannabis for therapeutic use, utilizing advanced greenhouse technology and automated cultivation systems to ensure standardized quality and consistency. Its operations encompass the entire supply chain, from plant genetics and breeding to the production of finished medicinal products, including oils and dried flower. Cann Group serves healthcare professionals and patients through established distribution channels and maintains a focus on research and development to advance cannabinoid-based treatments. The company leverages large-scale production capabilities to meet growing demand in both domestic and international medicinal markets, emphasizing rigorous quality control and compliance with international pharmaceutical standards.

Recent filings

Filing Released Lang Actions
Proposed issue of Securities - CAN 5 pages 27.6KB
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding a proposed issue of securities by Cann Group Limited. It details the number of securities to be issued, the issue price, approvals obtained, and other conditions related to the placement or issue of shares. There is no financial data, earnings information, or detailed report content. The document is focused on informing about a capital raising event or share issuance. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising or capital structure changes.
2020-08-10 English
Appendix 2A - Allotment of shares to Zalm Therapeutics 15 pages 303.8KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes detailed information about the entity, the type of securities being quoted, and references to previous announcements such as Appendix 3B. The document is a formal regulatory filing related to securities issuance and quotation, not a financial report, earnings release, or management discussion. It is a regulatory announcement about capital market activity, specifically the quotation of new securities. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is not a brief announcement or a report publication notice, but a full regulatory form submission.
2020-08-10 English
Cleansing statement - share issues to CSIRO and Zalm 1
Share Issue/Capital Change Classification · 95% confidence The document is an ASX announcement dated 11 August 2020, providing notice under section 708A(5)(e) of the Corporations Act 2001. It details the issuance of fully paid ordinary shares by way of placement to sophisticated investors without disclosure under Part 6D.2 of the Corporations Act. The notice confirms compliance with relevant sections of the Corporations Act and states there is no excluded information. The content focuses on share issuance and compliance notices rather than financial results, management changes, or detailed reports. The document length is short (2954 characters) and is a formal regulatory announcement about share placements and compliance. This fits the category of Share Issue/Capital Change (SHA) announcements rather than a full report or other filing types.
2020-08-10 English
Notice of General Meeting & Proxy Form 21 pages 2.0MB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Notice of General Meeting (GM) for Cann Group Limited scheduled for 7 September 2020. It includes details about the meeting time, resolutions to be voted on (such as ratification of share issues and participation of directors in placements), proxy voting instructions, and information about virtual attendance due to COVID-19. The document is not a report of financial results, audit, or earnings, nor is it a transcript or presentation. It is a formal notice sent to shareholders to inform them about the upcoming meeting and the business to be transacted. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2020-08-05 English
Cann Group to present at conference - 3 August 2020 1
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 31 July 2020 about Cann Group presenting at a virtual conference. It provides details about the event, presenters, and registration information. There is no financial data, no report attached or referenced as being published, and no regulatory certification or voting results. The document is essentially an investor presentation announcement or invitation rather than the presentation itself. Given the content and length (2071 characters), it is not a full investor presentation (IP) but rather an announcement about an upcoming presentation. According to the classification rules, announcements about presentations fall under Regulatory Filings (RNS) as a fallback category when the document does not contain the actual presentation or detailed financial data.
2020-07-30 English
Appendix 2A - Conversion of notes 16 pages 303.2KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 2A' and is an 'Application for quotation of securities' submitted to the ASX (Australian Securities Exchange). It includes detailed information about the entity, the type of securities being quoted, and the circumstances of the issue, such as options being exercised or convertible securities converted. This type of document is a formal regulatory announcement related to the listing and quotation of securities on the exchange. It is not a financial report, earnings release, or management discussion. It is also not a report publication announcement or certification. The document is a regulatory filing specific to securities quotation and issuance under ASX Listing Rules, which fits the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-07-28 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.